Phase 1/2 Study of MRTX849 for Patients with Cancer Having a KRAS G12C Mutation (KRYSTAL-1) | Clinical Trial

Phase 1/2 Study of MRTX849 for Patients with Cancer Having a KRAS G12C Mutation (KRYSTAL-1) | Clinical Trial | Right2Hope